Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma

NCT01507064 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Sorafenib
PROCEDURE: laser ablation (LA)

Sponsor

Cardarelli Hospital